The 2022 Digital Learning Journey on Diabetes and Pre-Diabetes

According to the global burden of disease in 2017, more than 4 million people worldwide died due to being overweight or obese1, and rates of obesity in both adults and children continue to rise globally. The World Health Organization defines those who are overweight or obese as having “abnormal or excessive fat accumulation that presents a risk to health”. Obesity leads to chronic inflammation, which occurs early in adipose tissue expansion, and continues during chronic obesity, irrespective of patient age. This chronic, systemic inflammation leads to insulin resistance, β-cell dysfunction, and ultimately to type 2 diabetes and contributes to the long-term consequences of diabetes, including cardiovascular disease, retinopathy and nephropathy. The scale of this issue is truly staggering – as well as the >4 million deaths from obesity, 6.7 million deaths were recorded in 2021 for which diabetes was responsible.2 This digital learning journey will focus on the impact of obesity and insulin resistance in the post-Covid-19 era, highlighting their consequences in special situations, such as pregnancy, and suggesting the best strategies to be implemented in clinical practice to try and stem the tide of early and preventable deaths.

1Dai H, et al. PLoS Med 2020;17(7):e1003198. doi: 10.1371/journal.pmed.1003198.

2International Diabetes Federation Diabetes Atlas 2021 – 10th edition. Available from: https://diabetesatlas.org/

All activities will be in English.

The video interview will have subtitles and the video lecture will have a voiceover in both Spanish and Chinese (Mandarin).

Upon completion of the diabetes digital learning journey, participants will be able to:

  • Describe the current trends and determinants of obesity and type 2 diabetes, and their consequences worldwide
  • Identify the consequences of obesity, insulin resistance and diabetes during pregnancy, and formulate best practice management strategies
  • Discuss how insulin resistance may increase cardiovascular risk beyond glycemia

Endocrinologists, Diabetologists, Specialists in Internal Medicine, General Practitioners

This learning journey is a structured e-learning educational program comprising:

  • Online Course: Obesity facts

LAUNCH: 31 May 2022

  • Video Interview: Gestational diabetes: Insulin resistance does matter

LAUNCH: 15 July 2022

  • Video Lecture: Benefits of insulin-sensitizer use early in the natural history of diabetes: Glycemia and beyond

LAUNCH: 15 October 2022

  • Expert Perspective: Early origins of vascular complications of diabetes

LAUNCH: 31 November 2022

Share on social

EDUCATIONAL RESOURCES

Hamdy Osama
Lopez Jaramillo
Pozzilli Paolo

Sara Bassetti | Progamme Manager | sara.bassetti@scientificseminars.com

This educational program is made possible thanks to an independent educational grant received from Merck Healthcare KGaA, Darmstadt, Germany.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

NEWSLETTER

[contact-form-7 id="442" title="Newsletter_EN"]

(c) 2022 SCIENTIFIC SEMINARS. All rights reserved – VAT 08448781008

(c) 2022 SCIENTIFIC SEMINARS. All rights reserved – VAT 08448781008

Scientific Seminars Foundation
This website uses cookies to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of all the cookies.
Warning: some page functionalities could not work due to your privacy choices